PQ 317
317. Deputy Erin McGreehan asked the Minister for Health the extent of engagement with patient advocacy organisations, including those representing prostate cancer patients, in relation to the reimbursement and provision of new treatments such as pluvicto. [50119/26]
Introduced
1 July 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
1 July 2026
Summary
317. Deputy Erin McGreehan asked the Minister for Health the extent of engagement with patient advocacy organisations, including those representing prostate cancer patients, in relation to the reimbursement and provision of new treatments such as pluvicto. [50119/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Disease Management
Disease Management
xml · EN · 1 July 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-07-01/317/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-07-01/pq_317